![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 25, 22822-22828, June 21, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 6, 2002, and in revised form, April 1, 2002
We have determined the solution structure of the
PABC domain from Saccharomyces cerevisiae Pab1p
and mapped its peptide-binding site. PABC domains are peptide binding
domains found in poly(A)-binding proteins (PABP) and are a subset of
HECT-family E3 ubiquitin ligases (also known as hyperplastic discs
proteins (HYDs)). In mammals, the PABC domain of PABP functions to
recruit several different translation factors to the mRNA poly(A)
tail. PABC domains are highly conserved, with high specificity for
peptide sequences of roughly 12 residues with conserved alanine,
phenylalanine, and proline residues at positions 7, 10, and 12. Compared with human PABP, the yeast PABC domain is missing the first
The yeast poly(A)-binding protein (Pab1p or
yPABP)1 is an essential
protein that functions as a scaffold to organize the mRNA ribonucleic acid protein complex around the mRNA poly(A) tail. Pab1p contains 570 amino acids arranged as four N-terminal RNA recognition motifs and a C-terminal PABC domain of ~70 amino acids. The two parts are separated by a largely unstructured region of ~100
amino acids. The N-terminal RNA recognition motifs bind the mRNA
poly(A) tail and interact with the eIF4F complex at the mRNA 5'
cap. This Pab1p-eIF4F interaction is important for the circularization of the mRNA in actively translating complexes (1). At the C terminus, the PABC domain acts as a peptide/protein binding domain, recruiting various translation or mRNA processing factors to the mRNA ribonucleic acid protein complex. In yeast, Pab1 is an
essential gene whose deletion leads to inhibition of translation
initiation, poly(A) shortening, and delay in the onset of mRNA
decay (2-4), but those effects can be suppressed by mutations that
alter the 60 S subunit of the ribosome as well as those that inhibit
mRNA decay (2, 5, 6).
In metazoans, several protein binding partners of PABC have been
identified. These include the PABP-interacting proteins Paip1 and Paip2
and heterogeneous nuclear ribonucleoprotein E (or The structures of PABC domains from human PABP (hPABP) and HYD (a human
ubiquitin ligase) have recently been determined by NMR spectroscopy and
x-ray crystallography (12, 13). The two structures are largely similar
and consist of 75 or 60 amino acid residues arranged as bundles of five
or four Here we report the structure of the PABC domain from the yeast
poly(A)-binding protein, Pab1p. The yeast sequence shows 40 and 57%
identity with the domains from hPABP and HYD (themselves 52%
identical). Together, the three proteins span much of the sequence
variation in PABC domains. The yeast structure shows several distinct
features that result in unique specificity and affinity of peptide binding.
Sequence Comparison of PABC Domains--
Forty sequences of PABC
domains were obtained from a yPABC Expression and Purification--
The C-terminal domain of
Pab1p, residues 491-577, was amplified by PCR using genomic DNA from
Saccharomyces cerevisiae (a gift from Malcolm
Whiteway) with primers PAByC-F (5'-CCCACAAGGTGGATCCCCAAGAAATGC-3') and
PAByC-R (5'-GTGATTACATGAATTCTTAAGCTTGCTCAG-3'). The PCR product was cloned into the BamHI and EcoRI restriction
sites of the vector pGEX-6P-1 (Amersham Biosciences). pPYC was
transformed into Escherichia coli expression host BL21 Gold
(DE3) (Stratagene) and grown at 37 °C in Luria Broth or M9 media
supplemented with 100 µg/ml ampicillin. Expression of the glutathione
S-transferase-yPABC fusion protein was induced at 30 °C
by 1 mM
isopropyl-1-thio- Peptide Preparation and Purification--
Unlabeled peptides
were synthesized by Fmoc (N-(9-fluorenyl)methoxycarbonyl)
solid-phase peptide synthesis and purified by reverse-phase
chromatography on a Vydac C18 column (Hesperia, CA). The
composition and purity of the peptides was verified by ion-spray
quadrupole mass spectroscopy.
The C-terminal domain of human Paip2, residues 106-127, was amplified
by PCR using a plasmid template (a gift of Nahum Sonenberg) with
primers P2C-F (5'-TCTTCTCTGGAAGGATCCGTGGTCAAGAGC-3') and P2C-R
(5'-CAGATGCACGACGAATTCTCAAATATTTCC-3'). The PCR product was
cloned into the BamHI and EcoRI restriction sites
of the vector pGEX-6P-1 (Amersham Biosciences) to make plasmid pP2C. An
15N-labeled peptide of this construct was made by
expressing pP2C in E. coli expression host BL21 Gold (DE3)
grown in M9 media containing 15NH4Cl and
purifying the fusion protein as described previously for yPABC.
Digestion with PreScission protease using the same conditions as
described above yielded a 27-residue peptide consisting of the 22 C-terminal residues of human Paip2 plus a 5-residue (Gly-Pro-Leu-Gly-Ser) N-terminal extension. The peptide was desalted using C18 reverse-phase chromatography and then
lyophilized. The composition and purity of the peptides was verified by
ion-spray quadrupole mass spectroscopy.
Peptide titrations were carried by adding either labeled or unlabeled
Paip2 peptide into unlabeled or labeled yPABC, respectively. Titrations
were monitored by 1H,15N heteronuclear single
quantum correlation spectra of the labeled species (either peptide or
protein) and were brought to a final protein concentration of 1 mM.
NMR Spectroscopy--
NMR resonance assignments of yPABC were
determined using standard triple resonance techniques on a
13C,15N-labeled sample (16) on a Bruker DRX500
NMR spectrometer. All NMR experiments were recorded at 303 K. Main-chain C Structure Calculations--
For the structure determination, a
set of 971 NOEs were collected from homonuclear and
15N-edited NOESY spectra of Pab1p-(491-577) acquired at
500 and 750 MHz, respectively. After determination of the protein fold using manual NOE assignments (25), automated NOE assignments were made
using ambiguous restraints for iterative assignment (ARIA) (26),
and the structure was refined using standard protocols in CNS version
0.9 (27). PROCHECK-NMR was used to check protein stereochemical
geometry and generate the Ramachandran plot of Fig. 2 (28). The
coordinates have been deposited in the Protein Data Bank under
accession code 1IFW, and the NMR assignments have been deposited under
BMRB accession number 5053.
The C-terminal fragment, yPABC, of Pab1p (residues 491-577; Fig.
1) from S. cerevisiae was
prepared as an isotopically labeled, recombinant protein fragment for
structural studies by NMR spectroscopy at 500 and 750 MHz. The yPABC
domain gave excellent quality spectra, and a large number of structural
constraints were determined (Table I). The secondary structure and NOEs were
very similar to human PABP, with the notable absence of the first The folded domain of yPABC includes ~65 residues (502-567 of Pab1p)
as a bundle of four helices (Fig. 3). The
overall fold is similar to the recently determined PABC structures from
human PABP (12) and HYD (13). The four helices (numbered 2-5) form a
compact structure with a well packed hydrophobic core consisting of
residues Leu-17, Leu-21, Val-25, Ala-32, Ala-33, Ile-36, Ile-40, Leu-43, Val-48, Phe-49, Leu-51, Leu-52, Phe-58, Tyr-62, Ala-65, Ala-68,
and Tyr-69. yPABC contains a unique two-amino acid insertion that is
accommodated in the loop between helices 2 and 3 (Fig. 1). The most
unusual feature of yPABC is the strong bend in the last
Solution Structure of the Orphan PABC Domain from
Saccharomyces cerevisiae Poly(A)-binding Protein*
,
,
,
,
, and
**
Departments of Biochemistry and
Chemistry, McGill University, Montreal, Quebec H3G 1Y6,
§ Biotechnology Research Institute, National Research
Council of Canada, Montreal, Quebec H4P 2R2, and ¶ Department of
Chemistry and Biochemistry, Concordia University,
Montreal, Quebec H3G 1M8, Canada
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
helix, contains two extra amino acids between helices 2 and 3, and
has a strongly bent C-terminal helix. These give rise to unique peptide binding specificity wherein yeast PABC binds peptides from Paip2 and
RF3 but not Paip1. Mapping of the peptide-binding site reveals that the
bend in the C-terminal helix disrupts binding interactions with the N
terminus of peptide ligands and leads to greatly reduced binding
affinity for the peptides tested. No high affinity or natural binding
partners from S. cerevisiae could be identified by sequence analysis of known PABC ligands. Comparison of the three
known PABC structures shows that the features responsible for peptide
binding are highly conserved and responsible for the distinct but
overlapping binding specificities.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
CP1 and -2) as
well as eRF3/GSPT (7-9). A number of potential interacting agents have also been identified in plants and yeast; they are Pab1p-binding protein (Pbp1p), eIF4B, Rna15p, and a viral
RNA-dependent RNA polymerase (4, 10, 11). We recently
showed that a large number of potential binding partners can be
identified by sequence analysis based on the presence of a consensus
PABC recognition site (12). Finally, it is notable that in addition to
poly(A)-binding proteins, PABC domains also occur in a subclass of
ubiquitin E3 protein ligases that contain a HECT
(homologous to E6-AP C
terminus) domain. The function of the PABC domain in these
ubiquitin ligases is unknown.
helices. Sequence conservation is highest in helices 2, 3, and 5, which correspond to the peptide-binding site determined by NMR
spectroscopy (12).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-BLAST search (14) of the NCBI
non-redundant data base with the yPABC sequence (gi417441, residues
490-563) as query. These unique sequences were analyzed by ClustalW to
generate an alignment and Neighbor Joining (NJ) tree (15). To simplify
comparisons between different PABC domains, we have adopted a numbering
scheme that is anchored on the KITGMLLE motif common to all PABC
domains. The PABC domain was defined to begin 34 residues before this
motif (36 residues in the case of yPABC). The two additional residues
in the loop between
helices 2 and 3 that are unique to the
Saccharomyces and Caenorhabditis proteins were
numbered 30a and 30b.
-D-galactopyranoside for 3 h and
purified by affinity chromatography using a glutathione-Sepharose 4B
column (Amersham Biosciences). The N-terminal glutathione
S-transferase tag was cleaved from yPABC by treatment for
20 h at 4 °C with PreScission protease (Amersham Biosciences)
on the column at 2.5 units/mg of fusion protein to yield a 92-residue
protein fragment consisting of the 87 C-terminal residues of Pab1p plus
a 5-residue (Gly-Pro-Leu-Gly-Ser) N-terminal extension.
Glutathione-Sepharose was used to remove the PreScission protease. The
sequence composition of purified yPABC was confirmed by mass
spectrometry. For NMR analysis, the protein was exchanged into NMR
buffer (50 mM K·HPO4, 100 mM
NaCl, 1 mM NaN3, pH 6.3). The final yield of
purified yPABC domain was 6 mg/liter culture (M9) media including
6 g of Na2HPO4, 3 g of
KH2PO4, 0.5 g of NaCl, 0.5 g of
15NH4Cl (Isotec, Inc.), and 2 g of
[13C6]glucose (Cambridge Isotope Laboratory).
, N, and HN and side-chain C
resonances were assigned using HNCACB and CBCA(CO)NH experiments (17, 18). H
resonance assignments and
3JHN-H
coupling constants were obtained from an HNHA experiment (19). 1H,15N dipolar couplings were measured with an
in-phase/anti-phase (IPAP)-heteronuclear single quantum correlation
experiment on an isotropic sample (without phage) and on a sample
containing 18 mg/ml Pf1 phage (20, 21). Other backbone and side-chain signal assignments were obtained from three-dimensional heteronuclear NOESY and total correlation spectroscopy experiments at 500 and 750 MHz
and a homonuclear two-dimensional NOESY experiment at 500 MHz. NOESY
constraints for the structure determination were obtained from
15N-edited NOESY and 13C-edited NOESY
three-dimensional experiments and two-dimensional homonuclear NOESY.
The 15N-NOESY spectrum was recorded on a Varian Unity Plus
750 MHz spectrometer at the Pacific Northwest National Laboratory.
Assignments of amide resonances in the yPABP-Paip2 complex were based
on an 1H,15N-edited NOESY spectrum obtained at
500 MHz. The 1H,15N heteronuclear NOEs were
measured at 500 MHz on a 15N-labeled Paip2 (residues
106-127) complexed with unlabeled yPABC (22). NMR spectra were
processed with GIFA (23) and XWINNMR software version 2.5 (Bruker Biospin) and analyzed with XEASY (24).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
helix (Fig. 2a). In addition
to NOE and dihedral angle constraints, a small set of 48 residual
dipolar couplings (RDCs) was measured on a sample of
15N-labeled yPABC in Pf1 phage (Fig. 2b). These
RDCs dramatically improved the precision of the structures,
particularly in the region of helix 4. The backbone r.m.s.d. in the
absence of RDCs was almost twice (0.61 Å) the final value for the 30 accepted structures (0.34 Å) calculated with RDCs. Inclusion of the
RDCs also improved the Ramachandran plot statistics (Fig. 2).

View larger version (39K):
[in a new window]
Fig. 1.
Sequence conservation in PABC domains from
PABP and HYD. a, PABC sequences from structures of
hPABP (12), hHYD (13), and S. cerevisiae Pab1p (yPABP).
Residue numbers in the intact protein are given along with the proposed
numbering scheme for residues within PABC. The domain from yeast
contains a 2-residue insertion after residue 30. Above the sequence
alignment, the positions of the four
helices in yPABP are shown.
hPABP contains an additional first helix (light gray) that
is absent in hHYD and yPABP. b, unrooted phylogenetic tree
of 40 PABC domains showing the grouping of plant, vertebrate, and HYD
sequences. Sequences labeled HYD are PABC domains from HECT E3
ubiquitin ligases (hyperplastic discs proteins); all other sequences
are poly(A)-binding proteins. The three proteins in panel a
are underlined. The figure was generated with ClustalW (15)
and TreeViewPPC (40).
Structural statistics

View larger version (34K):
[in a new window]
Fig. 2.
Structure determination of the yeast PABC
domain. a, histogram of long range (open
bars), medium range (light gray), sequential
(dark gray), and intraresidue NOEs (filled bars).
Only residues comprising the PABC domain as defined in Fig.
1a are shown. Yeast-specific residues 30a and 30b are
indicated by a gray bar. b, correlation of
experimental and back-calculated values for 48 1H,15N RDCs. c, plot of r.m.s.d.
(RMSF) of C
atoms in the 30 final structures
calculated without (gray) and with (black)
dipolar couplings. Inclusion of the RDCs doubles the precision of the
final ensemble.
helices in yeast PABP are shown as black
rectangles; the missing N-terminal helix found only in human PABC
is in gray. d, Ramachandran plot of the five
lowest energy structures calculated with RDCs.
helix. This
helix shows a roughly 50° bend centered around Tyr-62 and terminates
antiparallel with helix 3. Helix 5 contributes three aromatic residues
(Phe-58, Tyr-62, and Tyr-69) to the hydrophobic core. The bend can be
detected in the RDC data; parallel RDC experiments on hPABP confirm
that this is a unique feature of the yeast
domain.2 Surprisingly, all
the
/
angles in helix 5 fall in the most favored region of the
Ramachandran plot for
helices (Fig. 2d).

View larger version (53K):
[in a new window]
Fig. 3.
Structure of PABC domains. a,
stereoview of 30 yPABC structures showing residues in the aromatic-rich
hydrophobic core (light blue) and peptide-binding
site (green balls). b, ensemble turned 90° to
show the binding site in helices 2 and 3 (numbered as for hPABP).
c, enlargement of the peptide-binding site showing conserved
residues in yPABP (white), HYD (green), and hPABP
(blue). Despite two extra amino acids in yPABC (between
helix 2 and 3), the positions of residues involved in peptide binding
are highly conserved. Pairwise comparison of these same residues shows
that yPABP is more like HYD than hPABP. d-f, comparison of
the helix arrangement of PABC domains from hPABP (12), hHYD (13), and
yPABP. For hPABP and yPABC, the peptide-binding sites identified by
chemical shift mapping with a Paip2 peptide are shown (gray
surfaces). Peptide binding to yeast PABP likely occurs through the
same mechanism as identified for human PABP (12). The conserved peptide
phenylalanine residue (Table III) inserts into a hydrophobic pocket
between helices 2 and 3 and stacks with PABC residue Phe/Tyr-22. In
yeast, the strong bend in the C-terminal (red) helix gives
rise to an additional hydrophobic pocket (adjacent to residue Phe-72),
which may give rise to different specificity for peptide N-terminal
sequences (Table III).
As is the case for the HYD PABC domain, the yPABC domain is missing the
first helix. Instead, the fourth helix in yPABC is raised and replaces
a number of the contacts between helix 1 and 2 in hPABP (Fig. 3,
d-f). The first N-terminal helix of PABC from hPABP is
itself dispensable, and a shortened fragment (PABP residues 554-636)
gave a 1H,15N correlation spectrum similar to
that of the full-length domain (data not shown). Overall, the PABC
domain from yeast PABP appears to be more closely related to the PABC
domain from human HYD than human PABP. This is a consequence of the
greater sequence relatedness of yPABC and HYD but is more clearly
evident in the three-dimensional structures. A pairwise overlay of the
most conserved C
residues in the three proteins gives
over twice the r.m.s.d. for hPABP compared with HYD (Fig
3c).
Peptide binding studies were used to determine the specificity and
position of the peptide-binding site on yPABC. The initial choice of
peptides was based on the consensus binding sequence determined for the
human PABC (12). The list of peptides studied is shown in Table
II. Four peptides were found to bind to
yPABC. The 22-residue C-terminal peptide from Paip2 demonstrated one of
the highest affinities. Chemical shift mapping was used to identify
yPABC residues that participate in peptide binding (Fig. 4). Residues with the largest chemical
shift changes (((
1H shift)2 + (
15N shift × 0.2)2)1/2) on
binding of Paip2 were Lys-35 (0.6 ppm), Tyr-22 (0.47), Glu-19 (0.45),
Met-39 (0.39), Gln-20 (0.39), and Ile-40 (0.37). Only small chemical
shift changes were observed in helix 5 (Fig. 3), in contrast to
previous results with hPABP (12). Instead, almost all the chemical
shift changes occur in helices 2 and 3 around the hydrophobic binding
pocket, which is the presumed binding pocket for Phe-118 of Paip2.
Additional changes occur at the N terminus of helix 2 and likely
reflect interactions with the C-terminal portion of the peptide (see
below).
|
|
Yeast does not have a protein homologous to Paip2. Using the previously published consensus for human PABC (Table III), we searched the S. cerevisiae genome for related sequences that might bind to yPABC. Among proteins known to interact with Pab1p, we identified residues 234-250 from Pan1p (29, 30), two regions from Pbp1p (residues 308-327 and 376-399) (11), and a peptide derived from the N terminus of RF3 (residues 106-122) (Table II). None of these peptides bound to yPABC, as determined by the absence of chemical shift changes in 1H,15N correlation spectra. Similar negative results were obtained for a peptide derived from human Paip1. This was unexpected since Paip1 has been shown to bind to HYD (13). Of nine peptides tested, the four that bound were the Paip2 peptide, a peptide from the N terminus of human RF3, a peptide similar to Pichia pinus RF3, and a peptide from the Drosophila shuttle craft protein (Table II).
|
From titration experiments, we measured the dissociation constant of the Paip2 peptide-yPABC complex to be ~1 mM. Based on the similar amounts of line-broadening in spectra with other peptides, we estimate that the affinities of all the ligands tested are in the millimolar range. This is 3-4 orders of magnitude higher than that measured for Paip2/hPABP (7) and likely reflects the fact that the peptides do not interact with the C-terminal helix of yPABC.
We also monitored complex formation from the peptide side by cloning and expressing a 15N-labeled fragment of Paip2 (residues 106-127). The 1H,15N correlation spectrum of the unbound peptide showed the small dispersion of signals characteristic of an unfolded peptide (Fig. 4c). The addition of unlabeled yPABC to the 15N-labeled peptide caused changes in roughly half of the signals. The complex was in intermediate exchange, so many of the NMR peaks broadened or disappeared upon the addition of yPABC.
We identified peptide residues involved in PABC binding by an
1H,15N heteronuclear NOE (hNOE) experiment
(Fig. 4d). The hNOE is a measure of the reorientation rate
of the amide nitrogen-hydrogen internuclear vectors and, thus, of the
mobility of the peptide residues. At 500 MHz, the hNOE varies between
3.6 and 0.82 for mobile and immobile residues (22). For Paip2
residues Leu-103 to Leu-111 and Lys-123 to Ile-127, the hNOE was
negative, which indicates a lack of binding. Residues Asn-112 to
Val-122 gave small or zero hNOEs and identified these residues as
binding to yPABC. The absence of positive hNOEs is a reflection of the
weak binding of Paip2 to yPABC. For several residues in the middle of
the binding region, no hNOE signal could be detected. This was a
consequence of exchange broadening and constitutes independent evidence
for PABC binding by these residues. Residue Phe-118 of Paip2 showed the
largest hNOE, which is consistent with its key role in complex formation.
Previous studies identified a 12-residue consensus PABC site between
Ser-109 and Pro-120 of Paip2 (7). Our hNOE results suggest that this
motif is shifted toward the C terminus and includes Gly-121 and
Val-122. This agrees with on-going studies with PABC from human PABP,
which suggest that Paip2 binds hPABP as a series of
-turns.2 For yPABC, small negative hNOE values were
observed for residues Ser-109 through Leu-111. These negative hNOEs
likely reflect the differences in the structure and position of the
last
helix in yPABC and hPABP. Residues Ser-109 through Leu-111 do
bind hPABP but via helix 5.2 These results suggest that the
major specificity differences between PABC domains in human and yeast
PABP occur in the N-terminal residues of the peptide ligands due to the
altered structure of the terminal helices.
| |
DISCUSSION |
|---|
|
|
|---|
PABCs are highly conserved eukaryotic protein domains of 64-72 amino acids in length and sequence identities of 40% in interspecies comparisons. Three subfamilies can be distinguished in a phylogenetic tree of PABC sequences (Fig. 1b). The first group encompasses PABCs of animal origin, with overall pairwise identities of 80% or more (62% for C. elegans). Tissue-specific (testis) or -inducible (activated platelets or T cells) isoforms have been described in humans (31-33), and these sequences show a slightly lower level of identity when compared with other forms. This is likely the result of subcellular or tissue specialization, with conserved but distinct specificity among the different PABC domains within one organism.
A second branch groups a family of more divergent PABC domains of
vegetal origin with pairwise sequence identities of about 70%. PABC
from the parasite Trypanosoma brucei is branched with its
homologues in plants; this is supported by recent work that has hinted
at a weak phylogenetic link between the euglenozoan lineage (to which
trypanosomids belong) and plants (34). The third, most divergent group
contains the PABC domains of the ubiquitin ligases of the hyperplastic
discs (HYD) family as well as S. cerevisiae and
Schizosaccharomyces pombe PABPs. The relationship between HYD and PABP proteins has not yet been established, but it hints at a
role for ubiquitination in the regulation of protein synthesis. Structurally, the absence of the first
helix in yPABC and HYD seems
to be a feature of the third group of PABC domains. Secondary structure
predictions using the multivariate linear regression combination (MLRC)
software (35) as well as sequence conservation indicate the likely
presence of helix 1 in the wheat PABC domain and most other plant
PABCs, including trypanosomids, whereas the fungal PABC from
Aspergillus nidulans was predicted to harbor only four helices.
Limited data are available on the binding specificity of PABC domains. PABC from hPABP is known to bind a number of different proteins and peptides that were used to derive a consensus binding sequence or PABC site (12). The PABC domain of HYD has been shown to bind Paip1 (13). Here, we show that yPABC binds peptides from Paip2 and human RF3 but not Paip1. The failure of yPABC to bind Paip1 is surprising given the close similarity of Paip1 and Paip2 around the critical Phe-X-Pro sequence at the C terminus of the consensus motif (Table III). The phenylalanine is highly conserved and essential for binding.2 The weak affinities of the tested peptides suggest that a novel specificity exists for yPABC.
Among the proteins/peptides that bind to yPABC (Table II), only RF3 occurs in yeast. In S. cerevisiae, RF3 was first identified as the stop codon suppressor mutations Sup35 and Sup2 (36, 37). More recently, this protein has received considerable attention as it mediates non-mendelian inheritance through a prion-like mechanism. The yeast [PSI+] prion phenotype results from self-propagating aggregation of RF3 through its N-terminal domain (38). This behavior is thought to be related to the large number of glutamine residues at the N terminus.
Comparison of RF3 sequences from 11 different yeast species allowed us to identify potential PABC binding sequences in all but 4 species: S. cerevisiae, Zygosaccharomyces rouxii, Saccharomycodes ludwigii, and Kluyveromyces lactis (Table III). As is the case for human RF3, several of the RF3 proteins contain two or three potential PABC-binding sites. Yarrowia lipolytica RF3 contains three overlapping, putative PABC sites. It is unknown if all these sites are functional or if cooperativity exists between them. The absence of an evident PABC site in S. cerevisiae RF3 suggests that this interaction may be absent in baker's yeast and related strains. The four species missing PABC sites are most closely related to each other based on phylogenetic grouping of yeast using 23 S RNA sequences, which suggests that the site was lost relatively recently (38, 39).
Mangus et al. (11) used the C-terminal portion of Pab1p as bait in a two-hybrid screen for interacting yeast proteins. Surprisingly, none of the proteins identified contain a consensus PABC site. Instead, mutagenesis studies indicate that the region preceding yPABC (Pab1p residues 406-494) is required for the binding of Pbp1p (11). This preceding region is not a structured part of the C-terminal domain of yPABP (12, 13). Although Pbp1p does not bind PABC, it is related to ataxin-2, the human protein responsible for type 2 spinocerebellar ataxia (SCA2), which does contain a PABC site (11, 12). Perhaps coincidentally, the origin of SCA2 is a polyglutamine expansion in ataxin-2 that leads to protein aggregation as for RF3.
In conclusion, the structure of the PABC domain from the yeast
poly(A)-binding protein shows similarities to previous structures but
contains a very different C-terminal helix (Fig. 3). This gives rise to
a distinct binding specificity for yPABC, particularly toward the N
terminus of the bound peptides (Fig. 4). A hydrophobic pocket between
helices 3 and 5, which is unique to yPABC, could bind aromatic residues
that occur in the N-terminal end of PABC sites in fungal RF3 proteins
(Table III), but no PABC site was detected in RF3 from S. cerevisiae. Future work will be directed toward understanding the
function of yPABC in S. cerevisiae and in the
identification of physiological binding partners.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Malcolm Whiteway for the gift of S. cerevisiae genomic DNA, Nahum Sonenberg for the Paip2 plasmid, and David Mangus for helpful discussions. We acknowledge the Pacific Northwest National Laboratory for access to the Environmental Molecular Sciences Laboratory High Field Magnetic Resonance Facility.
| |
FOOTNOTES |
|---|
* This study was supported by Canadian Institutes of Health Research Grant 14219 (to K. G.). This is National Research Council Publication No. 44837.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1IFW) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
The NMR assignments for this protein are available in the BioMagnetic Resonance Bank (BMRB) database under BMRB accession number 5053 (www.bmrb.wise.edu).
** To whom correspondence should be addressed: Dept. of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC H3G 1Y6, Canada. Tel.: 514-496-2558; Fax: 514-398-7384; E-mail: kalle@bri.nrc.ca.
Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M201230200
2 G. Kozlov, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PABP, poly(A)-binding protein; yPABP, yeast PABP; hPABP, human PABP; HYD, hyperplastic discs protein; NOESY, nuclear Overhauser effect (NOE) spectroscopy; hNOE, heteronuclear NOE; RDC, residual dipolar coupling; r.m.s.d., root mean square deviation; eIF, eukaryotic initiation factor; E3, ubiquitin-protein isopeptide ligase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Wells, S. E., Hillner, P. E., Vale, R. D., and Sachs, A. B. (1998) Mol. Cell 2, 135-140[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Sachs, A. B., and Davis, R. W. (1989) Cell 58, 857-867[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Sachs, A. (1990) Curr. Opin. Cell Biol. 2, 1092-1098[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Amrani, N., Minet, M., Le, Gouar, M., Lacroute, F., and Wyers, F. (1997) Mol. Cell. Biol. 17, 3694-3701[Abstract] |
| 5. | Hatfield, L., Beelman, C. A., Stevens, A., and Parker, R. (1996) Mol. Cell. Biol. 16, 5830-5838[Abstract] |
| 6. |
Wyers, F.,
Minet, M.,
Dufour, M. E., Vo, L. T.,
and Lacroute, F.
(2000)
Mol. Cell. Biol.
20,
3538-3549 |
| 7. |
Khaleghpour, K.,
Kahvejian, A., De,
Crescenzo, G.,
Roy, G.,
Svitkin, Y. V.,
Imataka, H.,
O'Connor-McCourt, M.,
and Sonenberg, N.
(2001)
Mol. Cell. Biol.
21,
5200-5213 |
| 8. | Hoshino, S., Hosoda, N., Araki, Y., Kobayashi, T., Uchida, N., Funakoshi, Y., and Katada, T. (1999) Biochemistry (Mosc.) 64, 1367-1372[Medline] [Order article via Infotrieve] |
| 9. | Craig, A. W., Haghighat, A., Yu, A. T., and Sonenberg, N. (1998) Nature 392, 520-523[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Le, H.,
Tanguay, R. L.,
Balasta, M. L.,
Wei, C. C.,
Browning, K. S.,
Metz, A. M.,
Goss, D. J.,
and Gallie, D. R.
(1997)
J. Biol. Chem.
272,
16247-16255 |
| 11. |
Mangus, D. A.,
Amrani, N.,
and Jacobson, A.
(1998)
Mol. Cell. Biol.
18,
7383-7396 |
| 12. |
Kozlov, G.,
Trempe, J. F.,
Khaleghpour, K.,
Kahvejian, A.,
Ekiel, I.,
and Gehring, K.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4409-4413 |
| 13. |
Deo, R. C.,
Sonenberg, N.,
and Burley, S. K.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4414-4419 |
| 14. |
Altschul, S. F.,
Madden, T. L.,
Schäffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402 |
| 15. |
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680 |
| 16. | Bax, A., and Grzesiek, S. (1993) Acc. Chem. Res. 26, 131-138[CrossRef] |
| 17. | Grzesiek, S., Dobeli, H., Gentz, R., Garotta, G., Labhardt, A. M., and Bax, A. (1992) Biochemistry 31, 8180-8190[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Constantine, K. L., Goldfarb, V., Wittekind, M., Friedrichs, M. S., Anthony, J., Ng, S. C., and Mueller, L. (1993) J. Biomol. NMR 3, 41-54[Medline] [Order article via Infotrieve] |
| 19. | Kuboniwa, H., Grzesiek, S., Delaglio, F., and Bax, A. (1994) J. Biomol. NMR 4, 871-878[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Ottiger, M., Delaglio, F., and Bax, A. (1998) J. Magn. Reson. 131, 373-378[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Hansen, M. R., Mueller, L., and Pardi, A. (1998) Nat. Struct. Biol. 5, 1065-1074[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Peng, J. W., and Wagner, G. (1994) Methods Enzymol. 239, 563-596[Medline] [Order article via Infotrieve] |
| 23. | Malliavin, T., Pons, J.-L., and Delsuc, M.-A. (1996) J. Biomol. NMR 8, 445-452 |
| 24. | Bartels, C., Xia, T.-H., Billeter, M., Guntert, P., and Wüthrich, K. (1995) J. Biomol. NMR 5, 1-10[Medline] [Order article via Infotrieve] |
| 25. | Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids , John Wiley & Sons, Inc., New York |
| 26. | Nilges, M., Macias, M. J., O'Donoghue, S. I., and Oschkinat, H. (1997) J. Mol. Biol. 269, 408-422[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Brünger, A. T., Adams, P. D., Clore, G. M., Gros, P., Grosse-Kuntsleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., and Read, R. J. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R., and Thornton, J. M. (1996) J. Biomol. NMR 8, 477-486[Medline] [Order article via Infotrieve] |
| 29. |
Boeck, R.,
Tarun, S., Jr.,
Rieger, M.,
Deardorff, J. A.,
Muller-Auer, S.,
and Sachs, A. B.
(1996)
J. Biol. Chem.
271,
432-438 |
| 30. | Sachs, A. B., and Deardorff, J. A. (1992) Cell 70, 961-973[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Feral, C.,
Guellaen, G.,
and Pawlak, A.
(2001)
Nucleic Acids Res.
29,
1872-1883 |
| 32. | Houng, A. K., Maggini, L., Clement, C. Y., and Reed, G. L. (1997) Eur. J. Biochem. 243, 209-218[Medline] [Order article via Infotrieve] |
| 33. | Yang, H., Duckett, C. S., and Lindsten, T. (1995) Mol. Cell. Biol. 15, 6770-6776[Abstract] |
| 34. | Baldauf, S. L., Roger, A. J., Wenk-Siefert, I., and Doolittle, W. F. (2000) Science 290, 972-977[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Guermeur, Y.,
Geourjon, C.,
Gallinari, P.,
and Deleage, G.
(1999)
Bioinformatics
15,
413-421 |
| 36. | Stansfield, I., Jones, K. M., Kushnirov, V. V., Dagkesamanskaya, A. R., Poznyakovski, A. I., Paushkin, S. V., Nierras, C. R., Cox, B. S., Ter- Avanesyan, M. D., and Tuite, M. F. (1995) EMBO J. 14, 4365-4373[Medline] [Order article via Infotrieve] |
| 37. | Zhouravleva, G., Frolova, L., Le, Goff, X., Le, Guellec, R., Inge-Vechtomov, S., Kisselev, L., and Philippe, M. (1995) EMBO J. 14, 4065-4072[Medline] [Order article via Infotrieve] |
| 38. | Santoso, A., Chien, P., Osherovich, L. Z., and Weissman, J. S. (2000) Cell 100, 277-288[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Kushnirov, V. V., Ter-Avanesyan, M. D., Didichenko, S. A., Smirnov, V. N., Chernoff, Y. O., Derkach, I. L., Novikova, O. N., Inge-Vechtomov, S. G., Neistat, M. A., and Tolstorukov, I. I. (1990) Yeast 6, 461-472[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Page, R. D. M.
(1996)
Comput. Appl. Biosci.
12,
357-358 |
| 41. | Cornilescu, G., Marquardt, J. L., Ottiger, M., and Bax, A. (1998) J. Am. Chem. Soc. 120, 6836-6837[CrossRef] |
| 42. | Clore, M. G., and Garrett, D. S. (1999) J. Am. Chem. Soc. 121, 9008-9012[CrossRef] |
This article has been cited by other articles:
![]() |
E. Simon and B. Seraphin A specific role for the C-terminal region of the Poly(A)-binding protein in mRNA decay Nucleic Acids Res., September 25, 2007; 35(18): 6017 - 6028. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Siddiqui, D. A. Mangus, T.-C. Chang, J.-M. Palermino, A.-B. Shyu, and K. Gehring Poly(A) Nuclease Interacts with the C-terminal Domain of Polyadenylate-binding Protein Domain from Poly(A)-binding Protein J. Biol. Chem., August 24, 2007; 282(34): 25067 - 25075. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Lim, G. Kozlov, T.-C. Chang, O. Groover, N. Siddiqui, L. Volpon, G. De Crescenzo, A.-B. Shyu, and K. Gehring Comparative Peptide Binding Studies of the PABC Domains from the Ubiquitin-protein Isopeptide Ligase HYD and Poly(A)-binding Protein: IMPLICATIONS FOR HYD FUNCTION J. Biol. Chem., May 19, 2006; 281(20): 14376 - 14382. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Siddiqui, G. Kozlov, I. D'Orso, J.-F. Trempe, and K. Gehring Solution structure of the C-terminal domain from poly(A)-binding protein in Trypanosoma cruzi: A vegetal PABC domain Protein Sci., September 1, 2003; 12(9): 1925 - 1933. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |